Senior insider sale
President and COO at SYNDAX PHARMACEUTICALS INC — senior position signals high conviction
$130.0K
6.85K shares
What this filing means
METZGER MICHAEL A plans to sell 6.85K shares of SYNDAX PHARMACEUTICALS INC valued at approximately $130.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/1/2026ACC: 0001959173-26-004216
Officer· President and COO
Since Feb 2019
6.85K
Shares to sell
$130.0K
Approx. market value
6.85K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
5/29/2026
6.85KTotal acquired6.85K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/29/2026 | Restricted Stock Vesting Compensation | 6.85K | — |
| Total | 6.85K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
6.85K
Market value
$130.0K
6/1/2026
Total
Units
6.85K
Value
$130.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/1/2026 | 6.85K | $130.0K | NASDAQ | Planned |
| Total | 6.85K | $130.0K | ||